AT

Aptargroup IncNYSE ATR Stock Report

Last reporting period 30 Sep, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

10.398

Large

Exchange

XNYS - New York Stock Exchange, Inc

ATR Stock Analysis

AT

Neutral

Based on Eyestock quantitative analysis, ATR`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

74/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-10.3 %

Overvalued

Market cap $B

10.398

Dividend yield

1.27 %

Shares outstanding

65.4 B

AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. The company is headquartered in Crystal Lake, Illinois and currently employs 13,500 full-time employees. The firm operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment includes operations that sell dispensing systems, drug delivery systems, sealing solutions and services to the prescription drug, consumer health care, injectables, and active material science solutions markets. Beauty + Home segment includes operations that sells dispensing systems and sealing solutions primarily to the beauty, personal care and home care markets. The Food + Beverage segment includes operations that sell dispensing systems and sealing solutions to the food and beverage markets. The firm also manufactures and sells elastomeric primary packaging components. Its components are used in the injectables market. Its products include stoppers for infusion, antibiotic, lyophilization and diagnostic vials.

View Section: Eyestock Rating